Initial low-dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock.
Annika Janson 
;
Cathrin Hällström;
Magnus Iversen;
Mikael Finder;
Amira Elimam;
Ricard Nergårdh;
(2019)
Initial low-dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock.
CLINICAL CASE REPORTS, 7 (7).
pp. 1291-1296.
ISSN 2050-0904
DOI: 10.1002/ccr3.2169
;
Cathrin Hällström;
Magnus Iversen;
Mikael Finder;
Amira Elimam;
Ricard Nergårdh;
(2019)
Initial low-dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock.
CLINICAL CASE REPORTS, 7 (7).
pp. 1291-1296.
ISSN 2050-0904
DOI: 10.1002/ccr3.2169
Myxedema is extremely rare in children, and guidelines are lacking. We treated a 12-year-old girl with myxedema and cardiogenic shock with initial low dose (0.3-2.5 μg/kg body weight/day) of oral levothyroxine and intensive care. Oral administration may safely revert children's myxedema in a dosage resembling that for hypothyroidism.
-
picture_as_pdf - Initial low-dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads